Natixis Investment Managers International’s Biogen BIIB Stock Holding History

Natixis Investment Managers International’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-10,826	Closed	-$2.21M	–	262
2022 Q2	$2.21M	Buy	+10,826	New	+$2.21M	0.04%	114
2018 Q4	–	Sell	-3,463	Closed	-$1.22M	–	88
2018 Q3	$1.22M	Sell	3,463 -1,755	-34%	-$604K	0.06%	298
2018 Q2	$1.51M	Buy	5,218 +2,608	+100%	+$733K	0.08%	178
2018 Q1	$714K	Buy	+2,610	New	+$810K	0.05%	217
2016 Q3	–	Sell	-1,431	Closed	-$346K	–	370
2016 Q2	$346K	Buy	1,431 +67	+5%	+$17.7K	0.04%	290
2016 Q1	$355K	Buy	1,364 +61	+5%	+$16.1K	0.04%	245
2015 Q4	$399K	Hold	1,303	–	–	0.05%	197
2015 Q3	$380K	Sell	1,303 -95	-7%	-$31.4K	0.05%	239
2015 Q2	$565K	Buy	1,398 +43	+3%	+$17.3K	0.07%	171
2015 Q1	$572K	Sell	1,355 -216	-14%	-$85.1K	0.07%	166
2014 Q4	$533K	Buy	1,571 +1,054	+204%	+$341K	0.07%	175
2014 Q3	$171K	Sell	517 -529	-51%	-$174K	0.02%	168
2014 Q2	$330K	Hold	1,046	–	–	0.04%	160
2014 Q1	$320K	Buy	+1,046	New	+$332K	0.05%	131

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Natixis Investment Managers International's BIIB Position: Q3 2022 in Review

Natixis Investment Managers International sold out of Biogen (BIIB) in Q3 2022, closing a stake of 10,826 shares — an estimated $2.21M sold.

Natixis Investment Managers International first reported a position in BIIB in Q1 2014 and held it in 14 quarters. The position peaked at $2.21M in Q2 2022. 987 funds tracked by Wall St. Rank hold BIIB as of Q3 2022.

Natixis Investment Managers International reported no remaining Biogen position as of Q3 2022 after selling out during the quarter.
Natixis Investment Managers International sold 10,826 Biogen shares in Q3 2022, an estimated $2.21M.
Natixis Investment Managers International first reported a position in Biogen in Q1 2014 and held it in 14 quarters.
Natixis Investment Managers International's Biogen position peaked at $2.21M in Q2 2022.
987 funds tracked by Wall St. Rank held Biogen as of Q3 2022.

Based on Natixis Investment Managers International's 13F filing for Q3 2022, filed 14 Nov 2022.